BioSpace News Archive

Drug Development

Imcyse Continues Patient Enrolment in its Phase Ib Trial in Type 1 Diabetes

The trial is now recruiting patients at 15 clinical sites in four European countries and should open soon in France.

November 15, 2017

·

3 min read

Policy

Macrogen’s Clinical NGS Laboratory Receives CAP Accreditation

The accreditation was based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

November 15, 2017

·

2 min read

BioForest

Cardiac Insight Secures First Cardiology Customers for Its Wearable ECG Sensor, Cardea SOLO™

Early physician and patient experiences with Cardea SOLO are confirming the FDA-cleared cardiac device, designed to streamline arrhythmia detection in patients, is providing a higher standard of ambulatory cardiac care and efficiencies in cardiac practices.

November 15, 2017

·

4 min read

Drug Development

GeoVax HIV Clinical Trials Update

GeoVax Labs today announced that the HIV Vaccine Trials Network has closed enrollment for the phase 1 human clinical trial evaluating late boosts of GeoVax’s preventive vaccine (GOVX-B11) for clade B HIV.

November 15, 2017

·

4 min read

Business

Ceapro Reports 2017 Third Quarter Business Update and Financial Results

Total sales of $3,600,000 for the quarter ended September 30, 2017 compared to $3,018,000 in Q3 2016;

November 15, 2017

·

16 min read

Biotech Beach

Quanta Introduces Polarized Cannabis

Quanta, a biotech firm specializing in resonance energy, today announced the launch of its patented technology into the cannabis industry.

November 15, 2017

·

2 min read

Biotech Beach

InSource Diagnostics Release: New ToxLok Verifies Patient Sample ID in Urine Drug Tests New ToxLok Verifies Patient Sample ID in Urine Drug Tests

The test can identify synthetic urine as well as samples that might be obtained from a friend or relative.

November 15, 2017

·

1 min read

Business

Epigenomics Announces 2017 Third Quarter and Nine Months Financial Results

Total Q3 2017 revenue decreased to EUR 0.3 million and 9M 2017 revenue was at EUR 0.9 million.

November 15, 2017

·

5 min read

FDA

Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older

The new formulation and pediatric indication were approved through the FDA priority review process.

November 15, 2017

·

6 min read

Genetown

Autism Startup Raises 500% of its Goal in a Crowdfunding Campaign on its First Day

Brain Power’s campaign raised more money and a higher percentage of its goal in one day than any previous autism-related campaigns in their full 30 or 60 days on IndieGoGo, which is the second-largest crowdfunding platform in the world. The campaign also trended at #2 on the platform.

November 15, 2017

·

2 min read